Laurence Girard has built a unique position in American healthcare by enlisting physicians as investors in Fruit Street Health, a telehealth platform delivering CDC-recognised diabetes prevention programmes directly to consumers, signalling a shift towards scalable, reimbursement-ready preventive care.
Laurence Girard has built an unusual position in American healthcare: a founder who turned to physicians not only as customers and advisers but as investors. What began as a summer project at Harvard’s innovation hub has developed into Fruit Street Health, a telehealth-based diabetes prevention business aimed at helping people with prediabetes avoid progressing to type 2 diabetes through lifestyle change. Fruit Street says its service delivers the Centres for Disease Control and Prevention’s National Diabetes Prevention Programme remotely, using live group sessions with registered dietitians, wearable devices and app-based tracking.
Girard’s wider bet is that doctors can spot weak healthcare ideas faster than many traditional venture investors because they see broken workflows and poor outcomes every day. According to Healthcare Shares, the venture fund and studio he founded, the firm is organised around that logic, with Girard working alongside Christopher Meatto, an attorney and financial executive, and Dr Daniel Dow, a board-certified radiologist. Fruit Street and related summaries say Girard has raised capital from hundreds of physician backers, while one industry listing places Healthcare Shares’ funding at just under $800,000 across a single round.
Fruit Street’s programme is built around sustained behaviour change rather than medication. The company says participants meet in year-long group sessions, work with dietitians and are encouraged to reach a 5% to 7% reduction in body weight, a target widely used in prevention medicine. Earlier company announcements said the service was created to remove the need for in-person classes and that the platform expanded beyond employer or health-plan settings to a direct-to-consumer model. Diabetes advocacy group information also describes Fruit Street as CDC-recognised and available to the public.
The business has also gained public-sector attention. Fruit Street says the CDC granted it full recognition for delivering the programme by video, making it the first provider to achieve that status through live telemedicine. Separate company materials say the platform has enrolled more than 20,000 participants, while later reports describe federal engagement including involvement with a CDC implementation research network and inclusion in a CMS health technology ecosystem. Those appearances matter because they suggest the company has moved beyond an early-stage wellness concept and into the narrower world of reimbursable prevention infrastructure.
That broader context has become more relevant as GLP-1 drugs reshape the obesity and metabolic health market. The medicines have created new demand, but also a gap after the prescription: patients still need long-term support to change eating, activity and monitoring habits. Fruit Street’s model sits in that gap, and Girard’s pitch is that preventive care at scale is likely to matter more to employers and health plans than consumer-facing wellness trends aimed at affluent buyers.
Girard’s education and professional path have been as layered as his operating model. Healthcare Shares says he studied at Harvard Extension School and completed programmes at Harvard Business School and Columbia Business School, while later reports note additional study at London Business School and a current law degree track focused on intellectual property and life sciences. The same instinct appears in the firm’s structure: lawyers, doctors and operators rather than generalist financiers. For Girard, the thesis seems to be that healthcare is won less by charm than by credibility, regulation and access to the people who understand the system from the inside.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
